Internal Medicine, Infectious Disease · Saint Louis, MO
NPI
1144250028
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
621 S New Ballas Rd # 7018
Saint Louis, MO, 63141
Phone (314) 251-4949
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
659 services
Medicare patients, 2024
187
Average age 71
Drug cost, 2024
$642K
716 prescriptions
Company payments, 2025
$493
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jad A Khoury was code 99232 (hospital e&m - subsequent), 436 times for 115 patients. In total Jad A Khoury billed 659 services in 9 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 436 | 115 | $58.13 | $25K |
| 99222 Hospital E&M - Initial | Facility | 153 | 138 | $98.59 | $15K |
| 99214 Office E&M - Established | Office | 34 | 27 | $88.76 | $3,018 |
| 99204 Office E&M - New | Office | 17 | 17 | $117.57 | $1,999 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 11 | $12.60 | $151 |
By year: 2022 $60K for 863 services; 2023 $56K for 763 services; 2024 $46K for 659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jad A Khoury prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 78 prescriptions and refills. In total Jad A Khoury wrote 716 Medicare prescriptions that cost $642K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 78 | 78 | 19 | $4,358 |
| Methenamine Hippurate Generic | 73 | 121 | 14 | $5,889 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 69 | 69 | Under 11 | $307K |
| Daptomycin Generic | 64 | 64 | 13 | $9,519 |
| Doxycycline Hyclate Generic | 57 | 67 | Under 11 | $1,940 |
| Sodium Chloride 0.9 % Sodium Chloride | 37 | 37 | Under 11 | $425 |
| Cefuroxime Cefuroxime Axetil | 33 | 42 | Under 11 | $1,201 |
| Rifampin Generic | 33 | 39 | Under 11 | $2,349 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 32 | 32 | Under 11 | $123K |
| Fluconazole Generic | 24 | 24 | Under 11 | $990 |
| Azithromycin Generic | 22 | 30 | Under 11 | $209 |
| Teflaro Ceftaroline Fosamil Acetate | 20 | 20 | Under 11 | $65K |
| Cephalexin Generic | 18 | 32 | Under 11 | $487 |
| Valacyclovir Valacyclovir Hcl | 17 | 27 | Under 11 | $587 |
| Cefdinir Generic | 16 | 17 | Under 11 | $1,253 |
Brand drugs: 175 claims; generic drugs: 541 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jad A Khoury $493 ($493 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $179.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 13 | $179 |
| Abbvie Inc. ABBV | 4 | $74.91 |
| ViiV Healthcare Company GSK | 4 | $68.87 |
| Insmed, Inc. INSM | 2 | $37.7 |
| Aimmune Therapeutics, Inc. | 1 | $23.18 |
| Shionogi Inc 4507.T | 1 | $22.63 |
| Pfizer Inc. PFE | 1 | $18.85 |
| La Jolla Pharmaceutical Company | 1 | $18.69 |
| EMD Serono, Inc. MRK.DE | 1 | $17.99 |
| Merck Sharp & Dohme LLC MRK | 1 | $15.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.